Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Observation × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 8 Endometrial Neoplasms 8 Leukemia, Myeloid, Acute 7 Breast Neoplasms 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Lung Neoplasms 5 Colonic Neoplasms 5 Neoplasms 4 Multiple Myeloma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Lymphoma, Mantle-Cell 3 Esophageal Neoplasms 3 Brain Neoplasms 3 Anus Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Sarcoma 2 Recurrence 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2

Interventions

Temozolomide 140 Bevacizumab 63 Radiotherapy 54 Magnetic Resonance Spectroscopy 52 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 16 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡